 | • レポートコード：MRC2312MG00320 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、62ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の動物用幹細胞治療器市場規模と予測を収録しています。・世界の動物用幹細胞治療器市場：売上、2018年-2023年、2024年-2029年 ・世界の動物用幹細胞治療器市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の動物用幹細胞治療器市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「犬用幹細胞療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 動物用幹細胞治療器のグローバル主要企業は、Ardent Animal Health、 VetStem、 Medrego、 Vetbiologics、 Vetherapy、 Celavet、 Magellan Stem Cells、 Animal General、 Stem Care Company、 Animal Cell Therapies、 Cell Therapy Sciences、 Animacelなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、動物用幹細胞治療器のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の動物用幹細胞治療器市場：タイプ別、2018年-2023年、2024年-2029年 世界の動物用幹細胞治療器市場：タイプ別市場シェア、2022年 ・犬用幹細胞療法、馬用幹細胞療法、その他 世界の動物用幹細胞治療器市場：用途別、2018年-2023年、2024年-2029年 世界の動物用幹細胞治療器市場：用途別市場シェア、2022年 ・動物病院、研究機関 世界の動物用幹細胞治療器市場：地域・国別、2018年-2023年、2024年-2029年 世界の動物用幹細胞治療器市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における動物用幹細胞治療器のグローバル売上、2018年-2023年 ・主要企業における動物用幹細胞治療器のグローバル売上シェア、2022年 ・主要企業における動物用幹細胞治療器のグローバル販売量、2018年-2023年 ・主要企業における動物用幹細胞治療器のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Ardent Animal Health、 VetStem、 Medrego、 Vetbiologics、 Vetherapy、 Celavet、 Magellan Stem Cells、 Animal General、 Stem Care Company、 Animal Cell Therapies、 Cell Therapy Sciences、 Animacel ************************************************************* ・調査・分析レポートの概要 動物用幹細胞治療器市場の定義 市場セグメント 世界の動物用幹細胞治療器市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の動物用幹細胞治療器市場規模 世界の動物用幹細胞治療器市場規模：2022年 VS 2029年 世界の動物用幹細胞治療器市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの動物用幹細胞治療器の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の動物用幹細胞治療器製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：犬用幹細胞療法、馬用幹細胞療法、その他 動物用幹細胞治療器のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：動物病院、研究機関 動物用幹細胞治療器の用途別グローバル売上・予測 ・地域別市場分析 地域別動物用幹細胞治療器市場規模 2022年と2029年 地域別動物用幹細胞治療器売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Ardent Animal Health、 VetStem、 Medrego、 Vetbiologics、 Vetherapy、 Celavet、 Magellan Stem Cells、 Animal General、 Stem Care Company、 Animal Cell Therapies、 Cell Therapy Sciences、 Animacel ... |
This research report provides a comprehensive analysis of the Animal Stem Cell Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Animal Stem Cell Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Animal Stem Cell Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Animal Stem Cell Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Animal Stem Cell Therapy market presents opportunities for various stakeholders, including Veterinary Hospitals, Research Organizations. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Animal Stem Cell Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Animal Stem Cell Therapy market was valued at US$ 192.2 million in 2022 and is projected to reach US$ 472.8 million by 2029, at a CAGR of 13.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Key Features:
The research report on the Animal Stem Cell Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Animal Stem Cell Therapy market.
Market Overview: The report provides a comprehensive overview of the Animal Stem Cell Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Dogs Stem Cell Therapy, Horses Stem Cell Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Animal Stem Cell Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Animal Stem Cell Therapy market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Animal Stem Cell Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Animal Stem Cell Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Animal Stem Cell Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Animal Stem Cell Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Animal Stem Cell Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Animal Stem Cell Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Animal Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Market segment by Application
Veterinary Hospitals
Research Organizations
Global Animal Stem Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Outline of Major Chapters:
Chapter 1: Introduces the definition of Animal Stem Cell Therapy, market overview.
Chapter 2: Global Animal Stem Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Animal Stem Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Stem Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Animal Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Animal Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Animal Stem Cell Therapy Overall Market Size
2.1 Global Animal Stem Cell Therapy Market Size: 2022 VS 2029
2.2 Global Animal Stem Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Animal Stem Cell Therapy Players in Global Market
3.2 Top Global Animal Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Animal Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Animal Stem Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Animal Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Animal Stem Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Animal Stem Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Animal Stem Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Animal Stem Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 Dogs Stem Cell Therapy
4.1.3 Horses Stem Cell Therapy
4.1.4 Others
4.2 By Type – Global Animal Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type – Global Animal Stem Cell Therapy Revenue, 2018-2023
4.2.2 By Type – Global Animal Stem Cell Therapy Revenue, 2024-2029
4.2.3 By Type – Global Animal Stem Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Animal Stem Cell Therapy Market Size, 2022 & 2029
5.1.2 Veterinary Hospitals
5.1.3 Research Organizations
5.2 By Application – Global Animal Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application – Global Animal Stem Cell Therapy Revenue, 2018-2023
5.2.2 By Application – Global Animal Stem Cell Therapy Revenue, 2024-2029
5.2.3 By Application – Global Animal Stem Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Animal Stem Cell Therapy Market Size, 2022 & 2029
6.2 By Region – Global Animal Stem Cell Therapy Revenue & Forecasts
6.2.1 By Region – Global Animal Stem Cell Therapy Revenue, 2018-2023
6.2.2 By Region – Global Animal Stem Cell Therapy Revenue, 2024-2029
6.2.3 By Region – Global Animal Stem Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Animal Stem Cell Therapy Revenue, 2018-2029
6.3.2 US Animal Stem Cell Therapy Market Size, 2018-2029
6.3.3 Canada Animal Stem Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Animal Stem Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Animal Stem Cell Therapy Revenue, 2018-2029
6.4.2 Germany Animal Stem Cell Therapy Market Size, 2018-2029
6.4.3 France Animal Stem Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Animal Stem Cell Therapy Market Size, 2018-2029
6.4.5 Italy Animal Stem Cell Therapy Market Size, 2018-2029
6.4.6 Russia Animal Stem Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Animal Stem Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Animal Stem Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Animal Stem Cell Therapy Revenue, 2018-2029
6.5.2 China Animal Stem Cell Therapy Market Size, 2018-2029
6.5.3 Japan Animal Stem Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Animal Stem Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Animal Stem Cell Therapy Market Size, 2018-2029
6.5.6 India Animal Stem Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Animal Stem Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Animal Stem Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Animal Stem Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Animal Stem Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Animal Stem Cell Therapy Market Size, 2018-2029
6.7.3 Israel Animal Stem Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Animal Stem Cell Therapy Market Size, 2018-2029
6.7.5 UAE Animal Stem Cell Therapy Market Size, 2018-2029
7 Animal Stem Cell Therapy Companies Profiles
7.1 Ardent Animal Health
7.1.1 Ardent Animal Health Company Summary
7.1.2 Ardent Animal Health Business Overview
7.1.3 Ardent Animal Health Animal Stem Cell Therapy Major Product Offerings
7.1.4 Ardent Animal Health Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Ardent Animal Health Key News & Latest Developments
7.2 VetStem
7.2.1 VetStem Company Summary
7.2.2 VetStem Business Overview
7.2.3 VetStem Animal Stem Cell Therapy Major Product Offerings
7.2.4 VetStem Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 VetStem Key News & Latest Developments
7.3 Medrego
7.3.1 Medrego Company Summary
7.3.2 Medrego Business Overview
7.3.3 Medrego Animal Stem Cell Therapy Major Product Offerings
7.3.4 Medrego Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Medrego Key News & Latest Developments
7.4 Vetbiologics
7.4.1 Vetbiologics Company Summary
7.4.2 Vetbiologics Business Overview
7.4.3 Vetbiologics Animal Stem Cell Therapy Major Product Offerings
7.4.4 Vetbiologics Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Vetbiologics Key News & Latest Developments
7.5 Vetherapy
7.5.1 Vetherapy Company Summary
7.5.2 Vetherapy Business Overview
7.5.3 Vetherapy Animal Stem Cell Therapy Major Product Offerings
7.5.4 Vetherapy Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Vetherapy Key News & Latest Developments
7.6 Celavet
7.6.1 Celavet Company Summary
7.6.2 Celavet Business Overview
7.6.3 Celavet Animal Stem Cell Therapy Major Product Offerings
7.6.4 Celavet Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Celavet Key News & Latest Developments
7.7 Magellan Stem Cells
7.7.1 Magellan Stem Cells Company Summary
7.7.2 Magellan Stem Cells Business Overview
7.7.3 Magellan Stem Cells Animal Stem Cell Therapy Major Product Offerings
7.7.4 Magellan Stem Cells Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Magellan Stem Cells Key News & Latest Developments
7.8 Animal General
7.8.1 Animal General Company Summary
7.8.2 Animal General Business Overview
7.8.3 Animal General Animal Stem Cell Therapy Major Product Offerings
7.8.4 Animal General Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Animal General Key News & Latest Developments
7.9 Stem Care Company
7.9.1 Stem Care Company Company Summary
7.9.2 Stem Care Company Business Overview
7.9.3 Stem Care Company Animal Stem Cell Therapy Major Product Offerings
7.9.4 Stem Care Company Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Stem Care Company Key News & Latest Developments
7.10 Animal Cell Therapies
7.10.1 Animal Cell Therapies Company Summary
7.10.2 Animal Cell Therapies Business Overview
7.10.3 Animal Cell Therapies Animal Stem Cell Therapy Major Product Offerings
7.10.4 Animal Cell Therapies Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Animal Cell Therapies Key News & Latest Developments
7.11 Cell Therapy Sciences
7.11.1 Cell Therapy Sciences Company Summary
7.11.2 Cell Therapy Sciences Business Overview
7.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Major Product Offerings
7.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Cell Therapy Sciences Key News & Latest Developments
7.12 Animacel
7.12.1 Animacel Company Summary
7.12.2 Animacel Business Overview
7.12.3 Animacel Animal Stem Cell Therapy Major Product Offerings
7.12.4 Animacel Animal Stem Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Animacel Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer